Lentechs presbyopia contact lens promising in clinical trial
Click Here to Manage Email Alerts
Lentechs reported preliminary clinical trial results of an investigational contact lens designed for patients with presbyopia and presbyopia with astigmatism.
Apioc was developed to improve the visual compromise caused by multifocal contact lenses, according to a company press release. The lens is suspended behind the upper eyelid, which enables freer eye movement.
After 7 days, distance vision was improved compared with patients’ normal contact lenses and comparable with their normal prescription glasses. There were improvements in high- and low-contrast distance vision, and close vision and intermediate vision were maintained.
In addition, patients reported the comfort of Apioc was comparable to their normal contact lenses.
“These results provide tremendous evidence that Apioc helps solve the visual compromise caused by currently available multifocal contact lenses,” Robin G. Sears, president and CEO of Lentechs, said in the release. “Data show that only 10% to 15% of presbyopes currently wear contact lenses, yet 70% of glasses-wearing presbyopes want to wear them — Apioc will be the contact lens that finally helps bridge that divide for patients and practitioners.”
Read more about
Click Here to Manage Email Alerts